Eliglustat is a potent, specific inhibitor of the enzyme glucosylceramide synthase (GCS) and serves as a substrate reduction therapy (SRT) for adult patients with Gaucher disease type 1 (GD1). Here, UGCG is linked to Gaucher disease type 1.